Last reviewed · How we verify
NCT06628115: Cerament 2
Post Market Study of Cerament V/G in Pedal Osteomyelitis
NA trial testing cerament V or G in Osteomyelitis - Foot in 25 participants. Not yet recruiting.
1 October 2026
Quick facts
| Lead sponsor | Mid and South Essex NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 1 October 2024 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 November 2026 |
Drugs / interventions tested
- cerament V or G
Conditions studied
- Osteomyelitis - Foot — all drugs for Osteomyelitis - Foot →
Sponsor
Mid and South Essex NHS Foundation Trust
Who can join
18 and older, any sex, with Osteomyelitis - Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to look at the outcomes of patients who have had bone infection of their feet treated with a licensed antibiotic paste. The main question it aims to answer is: • How does the bone infection heal in response to the antibiotic paste? Participants will: * Undergo standard surgery to remove dead bone and drain any pus. * Antibiotic paste is injected directly into the middle of the bone at surgery. This is instead of receiving antibiotics directly into their bloodstream for 6 weeks. * Recieve one week of tablet antibiotics. * Visit clinic 1 month after surgery for a normal clinical appointment. After, a research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire. * Visit clinic 6 months and 12 months following the surgery. A research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06628115
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteomyelitis - Foot
Currently open trials in the same condition.
- NCT07266753 — Comparison of Oral Antibiotics For Bone Infections of the Leg and Foot · Phase 4 · recruiting
- NCT06388603 — RCT on Bioactive Glass S53P4 in Diabetic Foot Osteomyelitis in the Forefoot (DFORCT) · NA · recruiting
Other Mid and South Essex NHS Foundation Trust trials
Trials by the same sponsor.
- NCT06702306 — Duplex UltraSound afTer Endo Revascularisation - Feasibility Randomised Control Trial (DUSTER) · NA · active not recruiting
- NCT07173426 — Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure · NA · recruiting
- NCT06247761 — STASSH - TRAUMA - Absorbable vs Non-Absorbable Sutures in Trauma Hand Surgery · NA · unknown
- NCT05035771 — The IMPACT PAD Study · NA · unknown
- NCT05708131 — Outcomes of Functional Substrate Mapping of Ventricular Tachycardia · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06628115 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mid and South Essex NHS Foundation Trust
- Last refreshed: 4 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06628115.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing